244 related articles for article (PubMed ID: 29976344)
1. The use of gadolinium-based contrast agents in Ghana with a focus on residual intracranial gadolinium deposition.
Piersson AD; Gorleku PN
Radiography (Lond); 2018 Aug; 24(3):e51-e55. PubMed ID: 29976344
[TBL] [Abstract][Full Text] [Related]
2. Survey of gadolinium-based contrast agent utilization among the members of the Society for Pediatric Radiology: a Quality and Safety Committee report.
Blumfield E; Moore MM; Drake MK; Goodman TR; Lewis KN; Meyer LT; Ngo TD; Sammet C; Stanescu AL; Swenson DW; Slovis TL; Iyer RS
Pediatr Radiol; 2017 May; 47(6):665-673. PubMed ID: 28283728
[TBL] [Abstract][Full Text] [Related]
3. Nephrogenic systemic fibrosis: A survey of the use of gadolinium-based contrast agents in Ghana.
Piersson AD; Gorleku PN
Radiography (Lond); 2017 Nov; 23(4):e108-e113. PubMed ID: 28965904
[TBL] [Abstract][Full Text] [Related]
4. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
Frenzel T; Apte C; Jost G; Schöckel L; Lohrke J; Pietsch H
Invest Radiol; 2017 Jul; 52(7):396-404. PubMed ID: 28125438
[TBL] [Abstract][Full Text] [Related]
5. Gadolinium deposition within the dentate nucleus and globus pallidus after repeated administrations of gadolinium-based contrast agents-current status.
Stojanov D; Aracki-Trenkic A; Benedeto-Stojanov D
Neuroradiology; 2016 May; 58(5):433-41. PubMed ID: 26873830
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Gadolinium Deposition on Radiology Practice: An International Survey of Radiologists.
Fitzgerald RT; Agarwal V; Hoang JK; Gaillard F; Dixon A; Kanal E
Curr Probl Diagn Radiol; 2019; 48(3):220-223. PubMed ID: 29530452
[TBL] [Abstract][Full Text] [Related]
7. Gadolinium Brain Deposition after Macrocyclic Gadolinium Administration: A Pediatric Case-Control Study.
Tibussek D; Rademacher C; Caspers J; Turowski B; Schaper J; Antoch G; Klee D
Radiology; 2017 Oct; 285(1):223-230. PubMed ID: 28640695
[TBL] [Abstract][Full Text] [Related]
8. Gd accumulation in tissues of healthy mice upon repeated administrations of Gadodiamide and Gadoteridol.
Di Gregorio E; Iani R; Ferrauto G; Nuzzi R; Aime S; Gianolio E
J Trace Elem Med Biol; 2018 Jul; 48():239-245. PubMed ID: 29773187
[TBL] [Abstract][Full Text] [Related]
9. Gadolinium tissue deposition in the periodontal ligament of mice with reduced renal function exposed to Gd-based contrast agents.
Delfino R; Biasotto M; Candido R; Altissimo M; Stebel M; Salomè M; van Elteren JT; Vogel Mikuš K; Zennaro C; Šala M; Addobbati R; Tromba G; Pascolo L
Toxicol Lett; 2019 Feb; 301():157-167. PubMed ID: 30476537
[TBL] [Abstract][Full Text] [Related]
10. Increased signal intensities in the dentate nucleus and globus pallidus on unenhanced T1-weighted images: evidence in children undergoing multiple gadolinium MRI exams.
Hu HH; Pokorney A; Towbin RB; Miller JH
Pediatr Radiol; 2016 Oct; 46(11):1590-8. PubMed ID: 27282825
[TBL] [Abstract][Full Text] [Related]
11. Does renal function affect gadolinium deposition in the brain?
Rahatli FK; Donmez FY; Kibaroglu S; Kesim C; Haberal KM; Turnaoglu H; Agildere AM
Eur J Radiol; 2018 Jul; 104():33-37. PubMed ID: 29857863
[TBL] [Abstract][Full Text] [Related]
12. Brain gadolinium deposition after administration of gadolinium-based contrast agents.
Kanda T; Oba H; Toyoda K; Kitajima K; Furui S
Jpn J Radiol; 2016 Jan; 34(1):3-9. PubMed ID: 26608061
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Gadolinium Concentrations within Multiple Rat Organs after Intravenous Administration of Linear versus Macrocyclic Gadolinium Chelates.
McDonald RJ; McDonald JS; Dai D; Schroeder D; Jentoft ME; Murray DL; Kadirvel R; Eckel LJ; Kallmes DF
Radiology; 2017 Nov; 285(2):536-545. PubMed ID: 28640692
[TBL] [Abstract][Full Text] [Related]
14. Impact of chelation timing on gadolinium deposition in rats after contrast administration.
Prybylski JP; Coste Sanchez C; Jay M
Magn Reson Imaging; 2019 Jan; 55():140-144. PubMed ID: 30321663
[TBL] [Abstract][Full Text] [Related]
15. Distribution and chemical forms of gadolinium in the brain: a review.
Kanda T; Nakai Y; Hagiwara A; Oba H; Toyoda K; Furui S
Br J Radiol; 2017 Nov; 90(1079):20170115. PubMed ID: 28749164
[TBL] [Abstract][Full Text] [Related]
16. Skin Toxicity After Exposure to Gadolinium-Based Contrast Agents in Normal Renal Function, Using Clinical Approved Doses: Current Status of Preclinical and Clinical Studies.
Parillo M; Mallio CA; Van der Molen AJ; Rovira À; Ramalho J; Ramalho M; Gianolio E; Karst U; Radbruch A; Stroomberg G; Clement O; Dekkers IA; Nederveen AJ; Quattrocchi CC;
Invest Radiol; 2023 Aug; 58(8):530-538. PubMed ID: 37185158
[TBL] [Abstract][Full Text] [Related]
17. Gadolinium Deposition in the Brain: Current Updates.
Choi JW; Moon WJ
Korean J Radiol; 2019 Jan; 20(1):134-147. PubMed ID: 30627029
[TBL] [Abstract][Full Text] [Related]
18. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
Wiginton CD; Kelly B; Oto A; Jesse M; Aristimuno P; Ernst R; Chaljub G
AJR Am J Roentgenol; 2008 Apr; 190(4):1060-8. PubMed ID: 18356456
[TBL] [Abstract][Full Text] [Related]
19. Gadolinium presence, MRI hyperintensities, and glucose uptake in the hypoperfused rat brain after repeated administrations of gadodiamide.
Arena F; Bardini P; Blasi F; Gianolio E; Marini GM; La Cava F; Valbusa G; Aime S
Neuroradiology; 2019 Feb; 61(2):163-173. PubMed ID: 30377745
[TBL] [Abstract][Full Text] [Related]
20. Intrathecal Contrast-Enhanced Magnetic Resonance Imaging-Related Brain Signal Changes: Residual Gadolinium Deposition?
Öner AY; Barutcu B; Aykol Ş; Tali ET
Invest Radiol; 2017 Apr; 52(4):195-197. PubMed ID: 27755154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
